Ramaswamy B - Search Results

1

Viswanathan S, Ramaswamy B. Viswanathan S, et al. Among authors: ramaswamy b. Clin Obstet Gynecol. 2011 Dec;54(4):546-55. doi: 10.1097/GRF.0b013e318236e436. Clin Obstet Gynecol. 2011. PMID: 22031245 Review.

2

Phase II trial of bevacizumab in combination with docetaxel in women with advanced breast cancer.

Ramaswamy B, Shapiro CL. Ramaswamy B, et al. Clin Breast Cancer. 2003 Oct;4(4):292-4. doi: 10.3816/cbc.2003.n.035. Clin Breast Cancer. 2003. PMID: 14651775 Clinical Trial. No abstract available.

3

Osteopenia and osteoporosis in women with breast cancer.

Ramaswamy B, Shapiro CL. Ramaswamy B, et al. Semin Oncol. 2003 Dec;30(6):763-75. doi: 10.1053/j.seminoncol.2003.08.028. Semin Oncol. 2003. PMID: 14663777 Review.

4

Phase II trial of neoadjuvant chemotherapy with docetaxel followed by epirubicin in stage II/III breast cancer.

Ramaswamy B, Povoski SP, Rhoades C, Allen J, Hauger M, Young D, Burak W, Farrar W, Yee L, Kendra K, Somasundaram S, Orlowski RZ, Shapiro CL. Ramaswamy B, et al. Breast Cancer Res Treat. 2005 Sep;93(1):67-74. doi: 10.1007/s10549-005-3784-z. Breast Cancer Res Treat. 2005. PMID: 16184461 Clinical Trial.

5

Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients.

Ramaswamy B, Elias AD, Kelbick NT, Dodley A, Morrow M, Hauger M, Allen J, Rhoades C, Kendra K, Chen HX, Eckhardt SG, Shapiro CL. Ramaswamy B, et al. Clin Cancer Res. 2006 May 15;12(10):3124-9. doi: 10.1158/1078-0432.CCR-05-2603. Clin Cancer Res. 2006. PMID: 16707611 Clinical Trial.

6

Phase II study of weekly docetaxel and capecitabine in patients with metastatic breast cancer.

Mrozek E, Ramaswamy B, Young D, Rhoades CA, Kendra K, Allen J, Moore T, Hauger M, Watson H, Merriman N, Nadella P, Villalona-Calero M, Shapiro CL. Mrozek E, et al. Among authors: ramaswamy b. Clin Breast Cancer. 2006 Jun;7(2):141-5. doi: 10.3816/CBC.2006.n.023. Clin Breast Cancer. 2006. PMID: 16800973 Clinical Trial.

7

Association of major stressors with elevated risk of breast cancer incidence or relapse.

Pant S, Ramaswamy B. Pant S, et al. Among authors: ramaswamy b. Drugs Today (Barc). 2009 Feb;45(2):115-26. doi: 10.1358/dot.2009.45.2.1322480. Drugs Today (Barc). 2009. PMID: 19343231 Review.

8

Phase II trial of pyrazoloacridine (NSC#366140) in patients with metastatic breast cancer.

Ramaswamy B, Mrozek E, Kuebler JP, Bekaii-Saab T, Kraut EH. Ramaswamy B, et al. Invest New Drugs. 2011 Apr;29(2):347-51. doi: 10.1007/s10637-009-9338-1. Epub 2009 Oct 21. Invest New Drugs. 2011. PMID: 19844661 Free PMC article. Clinical Trial.

9

Epigenetic targeting in breast cancer: therapeutic impact and future direction.

Lustberg MB, Ramaswamy B. Lustberg MB, et al. Among authors: ramaswamy b. Drug News Perspect. 2009 Sep;22(7):369-81. doi: 10.1358/dnp.2009.22.7.1405072. Drug News Perspect. 2009. PMID: 19890494 Free PMC article. Review.

10

Phase II trial of neoadjuvant exemestane in combination with celecoxib in postmenopausal women who have breast cancer.

Lustberg MB, Povoski SP, Zhao W, Ziegler RM, Sugimoto Y, Ruppert AS, Lehman AM, Shiels DR, Mrozek E, Ramaswamy B, Layman RM, Brueggemeier RW, Shapiro CL. Lustberg MB, et al. Among authors: ramaswamy b. Clin Breast Cancer. 2011 Aug;11(4):221-7. doi: 10.1016/j.clbc.2011.03.022. Epub 2011 May 19. Clin Breast Cancer. 2011. PMID: 21729671 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

195 results

Search Page